Elements DNA
Aod15 · Metabolic
AOD-9604
MetabolicToday's deal · 69% off

AOD-9604

Modified C-terminal fragment of human growth hormone, residues 176 to 191

$25
Bundle and save

1 × $25 = $25. Applied in your cart.

1
  • Every batch tested by an independent laboratory — identity by HPLC and mass spec.
  • Dispatched on business days once payment has cleared. Free shipping over $100 — flat $10 otherwise.
  • Discreet packaging, tracked and insured on every shipment.

For laboratory and research use only · Not for human consumption

Class
Modified growth hormone fragment
Size
10mg
Molecular weight
1815.1 g/mol
Form
Lyophilised powder, sealed glass vial
Storage
Cool, dry and dark; refrigerate once reconstituted
Certificate status

What we test, every batch.

Each production lot of AOD-9604 is analysed by an independent laboratory before it ships. Its certificate is not in our published archive yet — we won't link one we don't hold.

Certificates we have published

The panel, every batch

Identity
HPLC + mass spec
Purity
HPLC · figure on the batch COA
Net peptide content
HPLC
Heavy metals
ICP-MS
Sterility
PCR
Endotoxin
USP <85>

What it is

AOD-9604 is a modified fragment of human growth hormone corresponding to residues 176 to 191 of the C-terminal region, with a tyrosine added at the N-terminus. Because it reproduces only a short segment of the parent hormone rather than the full 191-residue chain, researchers use it to separate the behaviour of that fragment from the receptor activity of the intact protein.

The peptide ships as a lyophilised powder in a sealed glass vial in a 10 mg presentation. Each lot carries a Certificate of Analysis covering identity and purity. Supplied for laboratory research use only, and not for human or veterinary use.

What the research explores

Interest in AOD-9604 stems from a structural question: which activities of growth hormone are carried by the C-terminal fragment, and which require the intact protein. Published preclinical work explores:

  • Lipid-metabolism signalling in isolated adipocyte and cell-culture systems
  • Comparison of fragment behaviour against full-length growth hormone at the GH receptor
  • Whether the fragment acts through pathways independent of the GH receptor
  • Stability and degradation profiles of the shortened sequence relative to the parent hormone

These describe laboratory research topics, not outcomes. Elements DNA makes no claim regarding effects in humans or animals and supplies this material exclusively for in vitro and preclinical use.

Questions

How should the vial be stored?

Keep the sealed vial cool, dry and shielded from light before opening. After reconstitution, store refrigerated and treat the solution as short-lived. Repeated freeze-thaw cycles degrade peptide integrity.

How is the lyophilised powder reconstituted?

Solvent is normally added slowly down the inside wall of the vial, then dissolved by gentle swirling rather than shaking. Solvent, concentration and protocol are the researcher's decision. We do not provide dosing or administration guidance.

What does the Certificate of Analysis cover?

The batch COA records compound identity and chromatographic purity for the lot shipped to you, alongside the lot identifier and test date. It is a laboratory characterisation document rather than any form of approval.

What arrives in the shipment?

One sealed 10 mg glass vial of lyophilised powder, protectively packaged and labelled with its batch identifier. Solvent, syringes and other consumables are not included.

Literature

7 publications · 2000–2017

Peer-reviewed publications indexed on PubMed that discuss AOD-9604. Listed for reference only — inclusion is not a claim about this product or its effects.

  1. 2017
    Human sports drug testing by mass spectrometry

    Schänzer W, Thevis M · Mass spectrometry reviews

    PMID 26213263 · doi 10.1002/mas.21479

  2. 2016
    Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry

    Thomas A, Görgens C, Guddat S, et al. · Journal of separation science

    PMID 26578461 · doi 10.1002/jssc.201501060

  3. 2015
    Detection and in vitro metabolism of AOD9604

    Cox HD, Smeal SJ, Hughes CM, et al. · Drug testing and analysis

    PMID 25208511 · doi 10.1002/dta.1715

  4. 2014
    Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604

    Vanhee C, Moens G, Deconinck E, et al. · Drug testing and analysis

    PMID 24976118 · doi 10.1002/dta.1687

  5. 2013
    AOD-9604 does not influence the WADA hGH isoform immunoassay

    Orlovius AK, Thomas A, Schänzer W, et al. · Drug testing and analysis

    PMID 24124033 · doi 10.1002/dta.1557

Show 2 more publications
  1. 2004
    AOD-9604 Metabolic

    Wilding J · Current opinion in investigational drugs (London, England : 2000)

    PMID 15134286

  2. 2000
    Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone

    Ng FM, Sun J, Sharma L, et al. · Hormone research

    PMID 11146367 · doi 10.1159/000053183

Researched alongside
Elora (AMY1R)
Metabolic
Standard
Semaglutide
Metabolic

Semaglutide

GLP-1 (SM)

$50
Standard
Cagrilintide
Metabolic
Standard
5-Amino-1MQ
Metabolic

Products are supplied strictly for laboratory and research use. They are not for human or veterinary consumption, and have not been evaluated by the U.S. Food and Drug Administration for the diagnosis, treatment, cure, or prevention of any condition.